RELATIONSHIP BETWEEN STUDY WITHDRAWAL AND BASELINE CHARACTERISTICS IN ADOLESCENTS AND ADULTS WITH MODERATE TO SEVERE PERSISTENT ASTHMA.

被引:0
|
作者
Rosenwasser, L. J.
Spector, S. L.
Uryniak, T.
Aggarwal, A.
Martin, U. J.
机构
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:A36 / A36
页数:1
相关论文
共 50 条
  • [1] RELATIONSHIP BETWEEN STUDY WITHDRAWAL AND BASELINE CHARACTERISTICS IN AFRICAN-AMERICAN PATIENTS WITH MODERATE TO SEVERE ASTHMA.
    Spector, S. L.
    Rosenwasser, L. J.
    Uryniak, T.
    Aggarwal, A.
    Martin, U. J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2011, 107 (05) : A36 - A37
  • [2] Triple inhaler therapy in adolescents and adults with moderate or severe persistent asthma
    L'Eplattenier, Mark
    Pontrelli, Gina
    Loscalzo, Carina
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2025, 38 (01): : e13 - e15
  • [3] Relationship Between Body Mass Index (BMI) and Baseline Characteristics in Non-Black and Black Populations With Moderate to Severe Persistent Asthma
    Spector, S. L.
    Uryniak, T.
    Martin, U. J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB153 - AB153
  • [4] Salmeterol (42 mu g BID) improves clinical outcomes in adolescents and adults with moderate to severe asthma.
    Murray, J
    Bowers, B
    Cox, F
    Emmett, A
    Kalberg, C
    Petrocella, V
    Rickard, K
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 1329 - 1329
  • [5] Bronchial thermoplasty for moderate or severe persistent asthma in adults
    Torrego, Alfons
    Sola, Ivan
    Maria Munoz, Ana
    Roqe i Figuls, Marta
    Jose Yepes-Nunez, Juan
    Alonso-Coello, Pablo
    Plaza, Vicente
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (03):
  • [6] Fluticasone in moderate-to-severe persistent asthma in adults
    Dusser, D
    Renon, D
    Pappo, M
    Lacronique, J
    REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE, 1999, 39 (07): : 567 - 573
  • [7] Effect of oral prednisone on the bronchoprotective effects by formoterol in patients with moderate to severe persistent asthma.
    Grootendorst, DC
    Sterk, PJ
    Heijerman, HGM
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A877 - A877
  • [8] ASTHMA SEVERITY AND INCREASED RISK OF CARDIOVASCULAR AND CEREBROVASCULAR OUTCOMES IN PATIENTS WITH MODERATE-TO-SEVERE PERSISTENT ASTHMA.
    Omachi, T. A.
    Haselkorn, T.
    Miller, D. P.
    Shah, M.
    Eisner, M. D.
    Chen, H.
    Iribarren, C.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2014, 113 (05) : A37 - A37
  • [9] Comparative trial of mometasone furoate versus fluticasone propionate in patients with moderate to severe persistent asthma.
    Sussman, G.
    Harnest, U.
    Price, D.
    Howes, T.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2007, 98 (01) : A59 - A59
  • [10] The Relationship Between Baseline Clinical Characteristics And Efficacy Of Omalizumab For 5 Years In Severe Asthma
    Watanabe, A.
    Houjyou, M.
    Nagase, H.
    Arai, H.
    Kuramochi, M.
    Ro, S.
    Tanaka, Y.
    Yamaguchi, M.
    Ohta, K.
    Sugiyama, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195